A5062984237- Schizophrenia research and treatment
- Treatment of Major Depression
- Urinary Tract Infections Management
- Pelvic floor disorders treatments
- Urinary Bladder and Prostate Research
- Mental Health and Psychiatry
- Tryptophan and brain disorders
- Obsessive-Compulsive Spectrum Disorders
- Pharmaceutical studies and practices
- Mental Health Treatment and Access
- Pharmacogenetics and Drug Metabolism
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Bipolar Disorder and Treatment
University of Missouri–Kansas City
2024
The University of Texas Health Science Center at San Antonio
2001
Mental Health Mental Retardation of Tarrant County
2001
San Antonio State Chest Hospital
1999
Austin College
1999
The University of Texas at Austin
1999
Unity Hospital
1996
Community Hospital
1996
A prospective, open-label study in a 400-bed state psychiatric hospital evaluated change therapeutic response among ten patients with treatment-resistant schizophrenia who were switched from clozapine to risperidone. Drug effects examined before discontinuation of and at three, six, nine, 12 weeks risperidone treatment. No improved, five discontinued treatment due exacerbation psychosis or adverse effects. Changes scores on the Positive Negative Syndrome Scale, Brief Psychiatric Rating...
Aripiprazole lauroxil (AL), a long-acting injectable antipsychotic, has 2 initiation options: 1-day (AL NanoCrystal Dispersion [AL
To investigate whether a relationship exists between the most common known cytochrome P450 (CYP) isozyme 2D6 mutations and schizophrenia. Because antipsychotic antidepressant agents interact with CYP2D6, we also investigated clinical outcomes in schizophrenic poor metabolizers (PMs) extensive (EMs).Prospective, observational study.Two psychiatric hospitals university-affiliated nonpsychiatric hospital.Thirty-nine consecutive patients (POP 1), 89 schizophrenics of French Canadian origin 2),...
OBJECTIVE: To report the use and subsequent failure of bladder-selective agent tolterodine, to treat clozapine-induced nocturnal enuresis in an adolescent patient with psychotic illness. CASE SUMMARY: A 16-year-old Hispanic girl was admitted state psychiatric hospital a diagnosis bipolar disorder features. Clozapine therapy initiated, after three months treatment began experiencing episodes enuresis. The tolterodine tried subsequently failed resolve episodes. Desmopressin which resulted...
Dear Editor:We read with interest Dr. VandenBerg's Psychopharmacology Pearl article1 in the October 2022 issue of Mental Health Clinician discussing recently approved long-acting injectable second-generation antipsychotics. We appreciate that articles reflect views and practices authors, substantiated evidence-based data as well professional opinion experience. However, we noticed inaccuracies regarding aripiprazole lauroxil (AL; Aristada, Alkermes Inc, Waltham, MA) VandenBerg article would...
AbstractOBJECTIVE:To report the use and subsequent failure of bladder-selective agent tolterodine, to treat clozapine-induced nocturnal enuresis in an adolescent patient with psychotic illness.CASE SUMMARY:A 16-year-old Hispanic girl was admitted state psychiatric hospital a diagnosis bipolar disorder features. Clozapine therapy initiated, after three months treatment began experiencing episodes enuresis. The tolterodine tried subsequently failed resolve episodes. Desmopressin which resulted...